 |
|
Associations of Clozapine Use With Psychosocial Functioning and Quality of Life in Patients With Schizophrenia: A Community-Based Cross-Sectional Study
Sujin Kim, Seoyoung Kim, Ah Young Choe, Euitae Kim
Psychiatry Investig. 2021;18(10):968-976. Published online 2021 Oct 8 DOI: https://doi.org/10.30773/pi.2021.0190
|
|
Exploring clozapine use in severe psychiatric symptoms associated with autism spectrum disorder: A scoping review
André Luiz Schuh Teixeira da Rosa, Olivia Sorato Bezerra, Luis Augusto Rohde, Ana Soledade Graeff-Martins
Journal of Psychopharmacology.2024; 38(4): 324. CrossRef Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, Andrea Fagiolini, Oliver D. Howes, Niko Seppälä, Christoph U. Correll
European Neuropsychopharmacology.2024; 84: 35. CrossRef Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Results on side effects
Mushde Shakir, Peter N. van Harten, Adriaan W. Hoogendoorn, Anne E. Willems, Diederik E. Tenback
Schizophrenia Research.2024; 274: 105. CrossRef
|